-
1401por Oxenkrug, Gregory F., Requintina, Pura J., Mikolich, Dennis L., Ruthazer, Robin, Viveiros, Kathleen, Lee, Hannah, Summergrad, Paul“…Predicting the efficacy of antiviral treatment of hepatitis C virus (HCV) is of importance for both patient well-being and health care expense. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1402por Ghobakhlou, Mehdi, Alizadeh, Amir Houshang Mohammad, Naderi, Nosratollah, Haghighi, Shirin, Molaei, Mahsa, Rafiezadeh, Mitra, Zali, Mohammad Reza“…We report a rare case of pancreas tumor (lymphoma) in a patient with a history of chronic hepatitis C virus (HCV) infection without treatment, with a high viral load (20,199,805 IU/ml). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1403“…Background. Hepatitis C virus (HCV) genotype 3 is known to cause steatosis (fatty liver) that is more frequent and severe than other genotypes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1404por Torbati, Elham, Bandehpour, Mojgan, Pakzad, Parviz, Mosaffa, Nariman, Koochaki, Ameneh, Kazemi, Bahram“…BACKGROUND: Hepatitis infection represents one of the important causes of morbidity and mortality in developing countries, however there is not any effective vaccine against hepatitis C which is one of the significant problems in vaccine project. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1405Self-Enhancement of Hepatitis C Virus Replication by Promotion of Specific Sphingolipid Biosynthesispor Hirata, Yuichi, Ikeda, Kazutaka, Sudoh, Masayuki, Tokunaga, Yuko, Suzuki, Akemi, Weng, Leiyun, Ohta, Masatoshi, Tobita, Yoshimi, Okano, Ken, Ozeki, Kazuhisa, Kawasaki, Kenichi, Tsukuda, Takuo, Katsume, Asao, Aoki, Yuko, Umehara, Takuya, Sekiguchi, Satoshi, Toyoda, Tetsuya, Shimotohno, Kunitada, Soga, Tomoyoshi, Nishijima, Masahiro, Taguchi, Ryo, Kohara, MichinoriEnlace del recurso
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1406por Li, Hui, Stoddard, Mark B., Wang, Shuyi, Blair, Lily M., Giorgi, Elena E., Parrish, Erica H., Learn, Gerald H., Hraber, Peter, Goepfert, Paul A., Saag, Michael S., Denny, Thomas N., Haynes, Barton F., Hahn, Beatrice H., Ribeiro, Ruy M., Perelson, Alan S., Korber, Bette T., Bhattacharya, Tanmoy, Shaw, George M.“…A precise molecular identification of transmitted hepatitis C virus (HCV) genomes could illuminate key aspects of transmission biology, immunopathogenesis and natural history. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1407por Herzer, Kerstin, Carbow, Anna, Sydor, Svenja, Sowa, Jan-Peter, Biesterfeld, Stefan, Hofmann, Thomas-Georg, Galle, Peter-Robert, Gerken, Guido, Canbay, Ali“…Overwhelming lines of epidemiological evidence have indicated that persistent infection with hepatitis C virus (HCV) is a major risk for the development of hepatocellular carcinoma (HCC). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1408por Naeem, Syed Saad, Siddiqui, Efaza Umar, Kazi, Abdul Nafey, Khan, SumaiyaTauseeq, Abdullah, Farhan E, Adhi, Idrees“…BACKGROUND: To report the findings of preoperative screening regarding prevalence of Hepatitis B and Hepatitis C in patients presenting for cataract surgery. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1409por Liu, Hongyan, Trinh, Thu Le, Dong, Huijia, Keith, Robertson, Nelson, David, Liu, Chen“…Hepatitis C viral infection affects 170 million people worldwide. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1410por Alghamdi, Abdullah S., Sanai, Faisal M., Ismail, Mona, Alghamdi, Hamdan, Alswat, Khalid, Alqutub, Adel, Altraif, Ibrahim, Shah, Hemant, Alfaleh, Faleh Z.Enlace del recurso
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1411“…The introduction of the nonimmunosuppressive cyclophilin inhibitors into clinical testing has confirmed the clinical utility of CsA-based inhibitors for the treatment of individuals with chronic hepatitis C infection and has yielded new insights into their mechanism(s) of action. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1412“…BACKGROUND: Latent autoimmune hepatitis (AIH) triggered during interferon (IFN) treatment in patients with chronic hepatitis C (CHC) is well known. Here, we report for the first time improvement of AIH using IFN and ribavirin (RBV) in a patient initially incorrectly diagnosed as having CHC. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1413por Taura, Naota, Fukushima, Nobuyoshi, Yatsuhashi, Hiroshi, Takami, Yuko, Seike, Masataka, Watanabe, Hiroshi, Mizuta, Toshihiko, Sasaki, Yutaka, Nagata, Kenji, Tabara, Akinari, Komorizono, Yasuji, Taketomi, Akinobu, Matsumoto, Shuichi, Tamai, Tsutomu, Muro, Toyokichi, Nakao, Kazuhiko, Fukuizumi, Kunitaka, Maeshiro, Tatsuji, Inoue, Osami, Sata, Michio“…CONCLUSIONS: The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased after 2001 in Kyushu area. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1414por Youssef, Samar Samir, Nasr, Aml S., El Zanaty, Taher, El Rawi, Rasha Sayed, Mattar, Mervat M.“…Background. Occult hepatitis C virus infection (OCI) was identified as a new form of Hepatitis C virus (HCV), characterized by undetectable HCV antibodies and HCV RNA in serum, while HCV RNA is detectable in liver and peripheral blood cells only. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1415“…Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections pose major public health problems because of their prevalence worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1416“…So far how hepatitis C virus (HCV) replication modulates subsequent virus growth and propagation still remains largely unknown. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1417por Li, Duan, Long, Yong, Wang, Tingcai, Xiao, Dan, Zhang, Jingxia, Guo, Zhiwen, Wang, Bo, Yan, Yongping“…The current HCV infection rate was 0.61% (44/7189) in the Wuwei general population. Hepatitis C infection rate was generally higher in the plains regions (χ(2) = 27.54,P<0.05), and the most predominant HCV genotypes were 2a (59.1%) and 1b (34.1%). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1418por Mustafa, Mubin, Hussain, Sofia, Qureshi, Saleem, Malik, Salman Akbar, Kazmi, Ali Raza, Naeem, Muhammad“…BACKGROUND: Hepatitis C virus (HCV) infection is one of the leading causes of chronic liver disease (CLD). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1419por Huang, Chung-Feng, Dai, Chia-Yen, Yeh, Ming-Lun, Huang, Jee-Fu, Huang, Ching-I, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Lin, Yi-Ching, Yu, Ming-Lung“…BACKGROUND/AIMS: The impact of virological factors and interleukin-28B (IL-28B) genetic variants on retreatment of hepatitis C virus genotype 2 (HCV-2) treatment-experienced patients remains unknown. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1420por Scheel, Troels K. H., Galli, Andrea, Li, Yi-Ping, Mikkelsen, Lotte S., Gottwein, Judith M., Bukh, Jens“…Although rare, epidemiologically important hepatitis C virus (HCV) recombinants have been reported. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto